Sunday, November 2, 2008

WORKUP of Dementia in Motor Neuron Disease

WORKUP of Dementia in Motor Neuron Disease


Lab Studies


Obtain typical blood studies, thyroid function tests, vitamin B12 and folate levels, and Venereal Disease Research Laboratory test. Refer to Amyotrophic Lateral Sclerosis for a full listing of the MND workup.

Imaging Studies


Computed tomography (CT) scan may show mild, generalized cerebral atrophy or asymmetric frontotemporal atrophy.
Because of greater resolution than CT, MRI studies may reveal selective frontal and anterior temporal atrophy that cannot be appreciated on CT.
Single photon emission computed tomography imaging often demonstrates reduced blood flow in an asymmetric, frontotemporal pattern.
A recent study reported that glucose hypometabolism on PET imaging in patients with dementia associated with motor neuron disease affected only the frontal lobes, sparing the temporal lobes. This is in contrast to frontotemporal dementia where glucose hypometabolism is seen in both frontal lobes and temporal lobes. In Alzheimer disease, PET scans may reveal glucose hypometabolism in the parietal and temporal regions bilaterally.

Other Tests


Electroencephalogram can remain normal even in later stages of dementia, but often mild dysrhythmic slowing occurs that is sometimes asymmetric.
Electromyography may demonstrate widespread denervation in limb muscles. Early in the disease, especially in predominantly bulbar onset patients, findings may not fulfill the Lambert or El Escorial criteria for MND.

Histologic Findings


Early in the disease, FTD/MND preferentially affects frontal and temporal lobes, the hypoglossal nucleus, and spinal motor neurons. Later and terminal stages reveal histologic evidence of widespread cortical involvement. In the frontal and temporal lobes, microscopic changes include loss of pyramidal cells, spongiform neuropil change, and astrocytic gliosis. Ubiquinated, tau-negative inclusions are present within the frontal cortex and the dentate gyrus of the hippocampus. Pick cells (inflated neurons) and Pick bodies (ubiquitin and tau-positive intracellular inclusions) are absent. Betz cells in the precentral gyrus usually are affected.

In approximately 50% of patients, neuronal loss and pigmentary incontinence in the substantia nigra and other pigmented brainstem neurons occurs, even in patients without clinically overt parkinsonism. There can be marked hypoglossal and spinal motor neuron degeneration (although this is not essential for patients to progress to an anarthric state) and ubiquinated tau-negative inclusions in the spinal neurons.

1 comment:

Jerry Atson said...

My father was diagnosed with ALS in the summer of 2013; His initial symptoms were quite noticeable. He first experienced weakness in his right arm and his speech and swallowing abilities were profoundly affected. We all did our best to seek help for this disease no medications they prescribe worked ,we were all scared we might lost him due to his condition, as he had been his brother's caregiver a few years earlier for the same disease before he past. doctor recommend nuatural treatment from total cure herbal foundation for his ALS we have no choice to give a try on natural organic treatment ,this herbal cure has effectively reverse my father condition ,losing his balance which led to stumbling and falling stop after the completing the herbal supplement which include his weakness in his right arm and his speech, home remedies from totalcureherbsfoundation com /totalcureherbalfoundation@ gmail. com is the best although their service is a little bit expensive but it worth it, they save lives.